跳至主要内容
临床试验/EUCTR2017-000922-37-AT
EUCTR2017-000922-37-AT进行中(未招募)1 期

Effects of continuous exercise on time spent in euglycemia and inflammation under the treatment of insulin degludec in patients with type 1 diabetes – a crossover, randomized trial (InflamEx)

Medical University of Graz0 个研究点目标入组 10 人开始时间: 2017年4月27日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1) Type 1 Diabetes
  • 2) Aged: 18 – 65 years (both inclusive)
  • 3) A1c 7 - 9% (53 – 75 mmol.mol-1) (both inclusive)
  • 4) Fasting c-peptide < 0.25 nmol.l-1 [21]
  • 5) Intensified insulin therapy
  • 6) Diabetes diagnosed > 12 months
  • 7) BMI 18.5 – 27 kg/m2 (both inclusive)
  • 8) more 150 min per week exercising with moderate intensity or more than 75 min per week exercising with high intensity
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 10
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1) Diabetic long-term complications
  • 2) Female of childbearing potential who is pregnant, breast-feeding or intend to become pregnant or is not using adequate contraceptive methods
  • 3) Illness or disease, that confound the study results
  • 4) Interference with insulin action
  • 5) Suspected allergy to trial products
  • 6) Addiction to alcohol
  • 7) Use of drugs
  • 8) Mental incapacity

研究者

发起方
Medical University of Graz

相似试验